Effective diabetes management requires a shift from focusing purely on blood sugar levels and weight management medications to embracing the psychological and biological contributors that drive obesity and the disease. The post The Dangerous Cycle of Anxiety and Diabetes appeared first on MedCity News.
Robert Krayn is the CEO and & Dr. Georgia Caveras the CMO of Talkiatry. Robert and Georgia are quite the dynamic duo (she says, “He’s the money I’m the medicine!”). As a relative latecomer in the online mental health world, Talkiatry is trying to differentiate itself from the other big players like Lyra, Headspace, Brightside…
No one AI technology will address everything and solve all problems, so systems should prioritize those that promise the greatest value and ROI. The post Why HCOs Need a Portfolio Management Approach to AI appeared first on MedCity News.
This brief provides an overview of DACA and who DACA recipients are and provides estimates of health coverage, work status, and income among individuals who meet eligibility criteria for DACA.
It’s that time of year again: open enrollment for Affordable Care Act insurance — a period that runs from tomorrow to Jan. 15 in most states, a bit longer in some, and shorter in Idaho. One of the biggest changes this time around: a new rule from the Biden administration that opens enrollment to Deferred…
KFF’s January 2025 Prescription Drug Advertisements Poll looks at the public’s experiences with prescription drug advertisements, whether they’ve talked to a doctor about advertised drugs, and how this has influenced the care they receive.
The FDA cited deficiencies in its govorestat’s application in galactosemia, a rare metabolic disease, Applied Therapeutics said. The biotech is still on track to submit a separate application for the drug in sorbitol dehydrogenase (SORD) deficiency, another rare disease that has no FDA-approved therapies. The post Applied Therapeutics Drug Is Denied FDA Approval in Rare…
It is time we realize that there is no single panacea for mental health; the need to break down barriers for working families and individuals in rural towns or underserved communities requires we move past a narrow definition of telehealth. The post The Miscalculation of Teletherapy: Why Digital Mental Health Goes Beyond Virtual Sessions appeared…
An Alto drug candidate for major depressive disorder failed to meet primary and secondary goals of a placebo-controlled Phase 2b test. The disappointing result could stymie plans for further tests of the small molecule in PTSD and bipolar depression. The post Alto Neuroscience’s Depression Trial Failure Sends Shares Into Downward Spiral appeared first on MedCity…
Prescriptions, GLP-1s and cancer are major contributors to employers’ healthcare costs, according to a new survey from the Business Group on Health. The post Business Group on Health: Healthcare Costs Expected to Surge at Highest Rate in 15 Years appeared first on MedCity News.